company background image
EVH logo

Evolent Health NYSE:EVH 株式レポート

最終価格

US$11.25

時価総額

US$1.3b

7D

-9.1%

1Y

-62.2%

更新

22 Nov, 2024

データ

会社財務 +

Evolent Health, Inc.

NYSE:EVH 株式レポート

時価総額:US$1.3b

EVH 株式概要

エボレント・ヘルス社は、その子会社であるエボレント・ヘルスLLCを通じて、米国において腫瘍、循環器、筋骨格系の専門医療管理サービスを提供している。 詳細

EVH ファンダメンタル分析
スノーフレーク・スコア
評価5/6
将来の成長4/6
過去の実績0/6
財務の健全性3/6
配当金0/6

Evolent Health, Inc. 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめEvolent Health
過去の株価
現在の株価US$11.25
52週高値US$35.00
52週安値US$11.17
ベータ1.59
11ヶ月の変化-49.78%
3ヶ月変化-65.88%
1年変化-62.18%
33年間の変化-57.19%
5年間の変化56.03%
IPOからの変化-40.35%

最新ニュース

Evolent Health: A Shot At Revival After Market Bruising

Nov 12

Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

Nov 09
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Recent updates

Evolent Health: A Shot At Revival After Market Bruising

Nov 12

Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

Nov 09
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

株主還元

EVHUS Healthcare ServicesUS 市場
7D-9.1%-5.2%0.3%
1Y-62.2%8.1%31.1%

業界別リターン: EVH過去 1 年間で8.1 % の収益を上げたUS Healthcare Services業界を下回りました。

リターン対市場: EVHは、過去 1 年間で31.1 % のリターンを上げたUS市場を下回りました。

価格変動

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement14.6%
Healthcare Services Industry Average Movement9.1%
Market Average Movement6.2%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

安定した株価: EVHの株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: EVHの weekly volatility ( 15% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
20114,700Seth Blackleywww.evolent.com

エボレント・ヘルス社は、子会社であるエボレント・ヘルスLLCを通じて、米国において腫瘍、循環器、筋骨格系の専門医療管理サービスを提供しています。エボレント・ヘルス社は、ヘルスケアプランの管理およびバリューベースのビジネスインフラのプラットフォームを提供しています。医療計画サービス、薬局給付管理、リスク管理、分析・報告、リーダーシップ・管理などの管理サービスや、データの集約・分析、ケアワークフローの管理、患者のエンゲージメントを行う独自の技術システムIdentifiを提供している。さらに、同社は包括的なトータル・コスト・オブ・ケア・マネジメントを提供している。エボレント・ヘルス社は2011年に設立され、バージニア州アーリントンに本社を置いている。

Evolent Health, Inc. 基礎のまとめ

Evolent Health の収益と売上を時価総額と比較するとどうか。
EVH 基礎統計学
時価総額US$1.33b
収益(TTM)-US$104.23m
売上高(TTM)US$2.46b

0.5x

P/Sレシオ

-12.4x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
EVH 損益計算書(TTM)
収益US$2.46b
売上原価US$2.07b
売上総利益US$393.27m
その他の費用US$497.50m
収益-US$104.23m

直近の収益報告

Sep 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)-0.91
グロス・マージン15.96%
純利益率-4.23%
有利子負債/自己資本比率48.9%

EVH の長期的なパフォーマンスは?

過去の実績と比較を見る